Related Experiment Video
Updated: Jul 20, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Vancomycin Hydrochloride as a Risk Factor for Acute Kidney Injury: A Retrospective Study
Shusuke Uekusa1, Yuki Hanai1, Shinobu Hirayama2
1Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Japan.
Introduction:
The incidence of acute kidney injury (AKI) caused by vancomycin hydrochloride (VCM) was reported to be 5-43%. VCM-induced AKI was reported to be more likely to occur 4-17 days after initiating VCM treatment; however, it may occur earlier. The aim of this study was therefore to investigate risk factors for the development of AKI within two (AKI2days) and seven (AKI7days) days of VCM administration.
Methods:
This was a single-center, retrospective study including patients who underwent VCM therapy between April 1, 2013, and December 31, 2019. AKI was evaluated based on the Kidney Disease: Improving Global Outcomes criteria.
Results:
In total, 287 patients were enrolled. The incidence of VCM-induced AKI within 7 days was 10.8% (31/286 cases), and the incidence of AKI within 2 days was 5.9% (15/252 cases). Serum VCM trough concentrations and tazobactam-piperacillin (TZP) were shown to be a risk factor for VCM-induced AKI. The serum VCM trough concentration was 12.67 μg/mL within the 48 h threshold (AKI2days) and 19.03 μg/mL within the 7-day threshold (AKI7days).
Conclusion:
Our study demonstrated that high serum VCM trough concentrations and the combination of VCM and TZP were independent risk factors for VCM-induced AKI. Avoiding the concomitant use of TZP, or thorough monitoring of renal function with the concomitant use of TZP, may be helpful in reducing the occurrence of AKI. Furthermore, monitoring serum VCM trough concentrations within 2 days may effectively reduce the incidence of AKI.
Insights
High vancomycin (VCM) levels and concurrent use of tazobactam-piperacillin (TZP) increase the risk of acute kidney injury (AKI). Early monitoring of VCM levels within two days can help reduce AKI incidence.
Area of Science:
- Pharmacology
- Nephrology
- Infectious Diseases
Background:
- Vancomycin hydrochloride (VCM) is associated with acute kidney injury (AKI), with reported incidence ranging from 5-43%.
- VCM-induced AKI typically occurs 4-17 days after treatment initiation but can manifest earlier.
- Identifying early risk factors for VCM-induced AKI is crucial for patient safety.
Purpose of the Study:
- To investigate risk factors for the development of AKI within two and seven days of VCM administration.
- To determine the incidence of early-onset VCM-induced AKI.
Main Methods:
- A retrospective, single-center study included 287 patients receiving VCM therapy from April 2013 to December 2019.
- AKI was diagnosed using Kidney Disease: Improving Global Outcomes (KDIGO) criteria.
- Risk factors, including serum VCM trough concentrations and concomitant medications, were analyzed.
Main Results:
- The incidence of VCM-induced AKI within 7 days was 10.8% (31/286), and within 2 days was 5.9% (15/252).
- Elevated serum VCM trough concentrations (12.67 μg/mL for AKI within 2 days, 19.03 μg/mL for AKI within 7 days) were identified as a risk factor.
- Concomitant use of tazobactam-piperacillin (TZP) was also a significant risk factor for VCM-induced AKI.
Conclusions:
- High serum VCM trough concentrations and concurrent VCM-TZP therapy are independent risk factors for VCM-induced AKI.
- Avoiding concomitant TZP or intensive renal function monitoring during combined therapy may mitigate AKI risk.
- Monitoring serum VCM trough concentrations within the first two days of treatment can effectively reduce AKI incidence.
More Related Videos
06:38Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
07:03Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Acute Kidney Injury VI: Nursing Management